Moderna Climbs 6% as Cancer Vaccine Trade Extends a 137% Month; BioNTech and Novavax Edge Higher
- Posted on September 17, 2026
- By AOL
- 0 Views
- 1 min read
In brief
Generating AI summary…
Moderna Climbs 6% as Cancer Vaccine Trade Extends a 137% Month; BioNTech and Novavax Edge Higher
Cancer vaccine momentum is doing the work for Moderna (NASDAQ:MRNA) once again on Thursday, extending one of the sharpest one-month runs in large-cap biotech this year without a fresh disclosure attached to it. Moderna stock is up 6% to $154 in morning trading, and the stock is up 137% over the past month. That extended […]
